1365 results
Imaging for aortic valve interventions
17 Feb 2023 – From PCR Tokyo Valves 2023
In this session, review the anatomy of the aortic valve system, learn how to assess low-flow, low-gradient severe AS, identify the pitfalls to avoid when assessing paravalvular leakage after TAVI, and find out more about how to detect valve thrombosis and degeneration, among others!
PCRonline @ ACC.23/WCC Scientific Sessions
23 Feb 2023
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology / World Heart Federation 2023 Scientific Sessions #ACC23 #WCCardio.
How to optimise procedural outcomes of TAVI in contemporary practice
05 Jan 2023
Watch the replay of this 3rd of #PCRtokyo 2022’s six live webinars with M. Lee, Y. Ohno, K. Shimamura and D. Tchétché.
Outlook on TAVI in Asian patients: how can the Navitor valve with the FlexNav delivery system enable successful procedural outcomes?
Watch this roundtable discussion between Dr Ravinder Singh Rao and Dr Norio Tada, moderated by Dr Michael Lee, to find out more about the prospects of TAVI in Asian patients.
This session will enable you to understand the special anatomical features of the Asian aortic valve stenosis...
Simultaneous aortography and left ventriculography for transcatheter valve-in-valve implantation in patients with a stentless bioprosthetic aortic valve
16 Dec 2022
Thanks to this image in cardiology, watch how an 82-year-old female patient underwent transcatheter ViV implantation for symptomatic severe SVD of the stentless pericardial bioprosthesis that had been implanted 4 years ago.
Optimising immediate and long-term outcomes after TAVI
15 Dec 2022 – From GulfPCR-GIM 2022
This session focuses on the use of the Acurate Neo2 valve in daily practice: watch it if you wish to learn how to determine clinical scenarios where the valve in question would be the best option, to find out more about lifetime management of AS patients...
Ultrasound supported thrombolysis: a live-saving procedure in massive saddle pulmonary embolism
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to learn how and why minimally invasive catheter directed thrombolytic therapy assisted by ultrasound can be effective and safe, even in massive pulmonary embolism with compromised RV function.
The why and how of performing a successful TAVI case
14 Dec 2022 – From GulfPCR-GIM 2022
In this GulfPCR-GIM 2022 session, observe a 72-year-old male patient with NYHA class II exertional dyspnoea, CAD status after revascularisation, type II DM, CKD IIIB, recently admitted for decompensated HF and type II NSTEMI, who was referred to the clinic for aortic valve replacement.
TAVI in 2022 - Lifetime management, durability and clinical relevance to patients
14 Dec 2022 – From GulfPCR-GIM 2022
In this session, a panel of experts address important issues on TAVR, especially regarding younger patients. Join them as they discuss lifetime management, valve durability, and the latest devices' role in extending re-intervention timelines.
Imaging in TAVI with challenging anatomy
14 Dec 2022 – From GulfPCR-GIM 2022
Through the 3 cases presented in this GulfPCR-GIM 2022 session and the highly informative discussion among your peers, learn how to use TAVI with difficult anatomies such as bicuspid aortic valves by relying on imaging.
Structural valve deterioration of a small aortic bioprosthesis. How should I treat?
16 Nov 2022
What would be your treatment strategy in this challenging case of a 78-year-old male patient with a failed surgical bioprosthetic valve implanted 17 years ago and complex coronary artery disease with chronic total occlusion of the right coronary artery?
Author
Author
Author
Structural valve deterioration of a supra-annular transcatheter aortic valve: How should I treat it?
29 Dec 2022
With the progressive increasing usage of TAVI in younger patients with longer life expectancy, the way to manage a failed transcatheter aortic valve will become an important issue.What would be your treatment strategy in this challenging case of an 86-year-old female patient with a failed supra-annular...
Author
Author
PCR London Valves 2022 - summaries of late-breaking science, trials and innovations
02 Dec 2022
Jonathan Curio provides a brief overview of the new data presented at PCR London Valves 2022 in the field of Tricuspid, TAVI and Mitral valves by providing summarised key take-aways!
Author
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
Clinical update and best practices for optimal large bore management with the MANTA closure device
29 Nov 2022 – From PCR London Valves 2022
Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.
Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.
TAVI-in-TAVI - A road map for successful lifetime management
29 Nov 2022 – From PCR London Valves 2022
Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.
Aortic stenosis and concomitant mitral valve disease
29 Nov 2022 – From PCR London Valves 2022
Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.
Aortic stenosis and concomitant coronary artery disease
29 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to aortic stenosis and concomitant coronary artery disease to learn how and when to screen for CAD in TAVI candidates, how to optimise your procedure to facilitate future coronary access, and to discover some tips and tricks for successful coronary angiography and PCI after TAVI.
TAVI challenges: session 4
29 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.
